This invention relates to preparations derived from amniotic fluid, and more specifically, to an amniotic fluid preparation with specific standardized measure of the biologic activity of a component of the preparation, such as a constituent protein, for use in clinical and research applications. The amniotic fluid preparation with standardized biologic activity resolves problems of establishing efficacy, safety, and reproducibility in the clinical and investigatory use of amniotic fluid-derived preparations for the treatment of a wide range of degenerative illnesses, traumatic injuries, tissue and organ transplantation, and other medical conditions.
